Short answer: When a UK clinic uses a laser, IPL or LED product that is a regulated medical device, an adverse incident may need a medical-device report through the route applicable to its location. The MHRA’s Yellow Card guidance says organizations in England, Wales and Northern Ireland should report medical-device problems through Yellow Card in line with their policies. Scotland has a different pathway for many facilities. A sensible clinic procedure should distinguish immediate care, preserving evidence and internal escalation from making the external report. The form is not a substitute for helping the injured person.
Current UK routes are not identical
The MHRA guidance was first published in January 2015 and last updated on 24 July 2025. That update explains a change for Northern Ireland from 1 August 2025, when healthcare professionals began reporting device incidents through Yellow Card after the Northern Ireland Adverse Incident Centre function closed. The page says England, Wales and Northern Ireland use Yellow Card according to organization policies. For Scotland, it directs users to a Health Facilities Scotland online system, while private facilities caring for private clients should report to MHRA and the Care Inspectorate. A UK-wide template that points everyone to one inbox could therefore send information to the wrong place.
The guidance applies to medical devices. It does not establish that every cosmetic light product is a medical device, nor that the same route covers every service complaint. A buyer should obtain the intended use and regulatory status of the exact model, and the operator should seek advice on the appropriate incident route for that product and facility. Do not delay urgent assistance while debating the product classification.
What an operator should prepare
Before launching a service, assign a person who records the event, secures the device and accessory configuration, and contacts the supplier. Record the model, serial or other identifier, software version where relevant, consumables, settings as displayed, date, location, staff present and what happened. Keep client details confidential in the appropriate record system. If a fault is suspected, pause use until competent personnel assess it. Preserve relevant labels, maintenance logs and instructions. These are practical preparedness steps inferred from the purpose of incident reporting; the MHRA page does not prescribe one universal clinic form.
Provide staff with a short escalation card: care first, internal notification next, then the jurisdiction-specific reporting decision. A patient or member of the public may also report. Explain what to do if an incident emerges later, such as a delayed injury or discovered device defect. The MHRA notes that reports help identify new product problems. A report is a safety signal, not proof that a product caused the event or that a regulator has reached a final conclusion.
Limits
This article covers reporting pathways for UK medical devices, not treatment instructions, mandatory deadlines or a legal classification of any TUOKE product. The MHRA page is standing guidance updated in 2025, not a new 2026 incident. Requirements may vary with the facility and device. Check current MHRA and devolved-nation guidance, organizational policy and professional obligations before settling a procedure. Do not infer that a competitor incident concerns TUOKE.
Related purchasing and operational questions appear in TUOKE’s optical aesthetic equipment insights.
Source
Medicines and Healthcare products Regulatory Agency, The Yellow Card scheme guidance, published 23 January 2015, updated 24 July 2025; reviewed 15 October 2026.